CG Oncology Inc.

Last updated September 27, 2026

Organization details

Legal name
CG Oncology Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
CGON
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001991792

Board of directors

Chief executives

Arthur Kuan · Chief Executive Officer
Since January 2024

Board connections

4 of this board's directors also sit on 3 other boards.

Network of CG Oncology Inc.'s board connections Aardvark Therapeutics Inc. Aardvark Therapeutics... Xilio Therapeutics Inc. Xilio Therapeutics Inc... uniQure N.V. uniQure N.V. Christina Rossi Christina Rossi Leonard E. Post Leonard E. Post Susan E. Graf Susan E. Graf Victor Edward Tong Jr. Victor Edward Tong J... CG Oncology Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$24,814,454
1 purchase by 1 insider
Sold, last 12 months
$5,702,667
18 sales by 2 insiders
Date Insider Transaction Shares Price Value
Aug 14, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Aug 14, 2026 Leonard E. Post Director Open-market sale −1,000 $74.54 $74,540
Jul 15, 2026 Leonard E. Post Director Option exercise +1,000 $0.60 $600
Jul 15, 2026 Leonard E. Post Director Open-market sale −1,000 $71.17 $71,170
Jul 10, 2026 James Mulay Director Option exercise +24,165 $26.63 $643,514
Jul 10, 2026 James Mulay Director Open-market sale −24,165 $75.16 $1,816,241
Jun 25, 2026 Brian Guan-Chyun Liu Director Open-market purchase +371,085 $66.87 $24,814,454
Jun 24, 2026 Leonard E. Post Director Option exercise +5,000 $0.60 $3,000
Jun 24, 2026 Leonard E. Post Director Open-market sale −5,000 $70.00 $350,000
Jun 22, 2026 Leonard E. Post Director Option exercise +5,000 $0.60 $3,000
Jun 22, 2026 Leonard E. Post Director Open-market sale −5,000 $65.00 $325,000
Jun 15, 2026 James Mulay Director Option exercise +654 $3.72 $2,433
Jun 15, 2026 James Mulay Director Open-market sale −654 $60.12 $39,318
Jun 15, 2026 James Mulay Director Option exercise +1,310 $12.59 $16,493
Jun 15, 2026 James Mulay Director Open-market sale −1,310 $60.12 $78,757

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.